Prediction of hepatic encephalopathy development in patients with severe acute hepatitis

Digestive Diseases and Sciences

Volumn 51, Issue 2, 2006, Pages 359-364

  Takikawa, Yasuhiro ^a   Endo, Ryujin ^a   Suzuki, Kazuyuki ^a   Fujiwara, Kenji ^b   Omata, Masao ^c  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Acute hepatitis; Fulminant hepatitis; Hepatic encephalopathy; Non A E hepatitis; Prediction; Prothrombin time

Indexed keywords

BILIRUBIN;

ACUTE HEPATITIS; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL RATE;

ADULT; AGE FACTORS; ALGORITHMS; BILIRUBIN; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTHROMBIN TIME; RISK FACTORS; ROC CURVE;

EID: 33644928338     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-3138-7     Document Type: Article

References (18)

1. Shunichi S, Kazuyuki S, Yasuhiro T, Ryujin E, Masao O, the Japanese National Study Group of Fulminant Hepatitis: Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey. Hepatol Res 30:155-161, 2004
2. Fujiwara K: Japanese national survey of FH in 2000. In The 2001 Annual Report of Research Group of Intractable Hepatitis, Tokyo, The Ministry of Health and Welfare of Japan, 2002, pp 87-96 (in Japanese)
3. Trey C, Lipworth L, Dabidson CS: Parameters influencing survival in the first 318 patients reported to the fulminant hepatic failure surveillance study. Gastroenterology 58:306, 1970
4. Horney JT, Galambos JT: The liver during and after fulminant hepatitis. Gastroenterology 73:639-645, 1977
5. Kita Y, Umeshita K, Gotoh M, et al.: Quality of life in adult Japanese patients undergoing liver transplants overseas. Transplant Proc 28:1934-1936, 1996
6. Humar A: Donor and recipient outcomes after adult living donor liver transplantation. Liver Transpl 9(Suppl 2):S42-S44, 2003
7. Yoshiba M, Inoue K, Sekiyama K, Koh I: Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs 11:1169-1172, 1996
8. Sadahiro T, Hirasawa H, Oda S, et al.: Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure. Crit Care Med 29:1386-1392, 2001
9. Trey C, Davidson CS: The management of fulminant hepatic failure. In Progress in Liver Disease, vol III. Popper H, Schaffner F (eds). New York, Grune & Stratton, 1970, pp 282-298
10. Hosmer DW, Lemeshow S: Assessing the fit of the model. In Applied Logistic Regression. Hosmer DW, Lemeshow S (eds). New York, John Willy & Sons, 1989, pp 135-175
11. Trey C, Lipworth L, Chalmers TC, et al.: Fulminant hepatic failure. Presumable contribution to halothane. N Engl J Med 279:798-801, 1968
12. O'Grady JG, Schalm SW, Williams R: Acute liver failure: redefining the syndromes. Lancet 342:273-275, 1993
13. Muto Y: Present status of fulminant hepatitis in Japan. Gastroenterol Jpn 28(Suppl 4):120-127, 1993
14. Elinav E, Ben-Dov I, Hai-Am E, Ackerman Z, Ofran Y: The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy. J Hepatol 42:82-86, 2005
15. McNeil M, Hoy JF, Richards MJ, et al.: Aetiology of fatal viral hepatitis in Melbourne. A retrospective study. Med J Aust 141:637-640, 1984
16. Papaevangelou G, Tassopoulos N, Roumeliotou-Karayannis A, Richardson C: Etiology of fulminant viral hepatitis in Greece. Hepatology 4:369-372, 1984
17. Kim WR, Brown RS Jr., Terrault NA, El-Serag H: Burden of liver disease in the United States: summary of a workshop. Hepatology 36:227-242, 2002
18. O'Grady JG, Alexander GJ, Hayliar KM, Williams R: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439-445, 1989